U.S. markets closed

WeedMD Inc. (WMD.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.5400-0.0200 (-3.57%)
At close: 12:33PM EST
Sign in to post a message.
  • N
    Nick
    News out. WeedMD's Starseed Medicinal Announces the Release of Strain-Specific Products for PAX(R) ERA(R) Vaporizer

    COMTEX - Updated 37 minutes ago
    GlobeNewswire
    WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) ("WeedMD" or the "Company"), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce it will commence selling Pedro's Sweet Sativa, strain-specific PAX(R) ERA(R) products to its Starseed Medicinal clients starting March 6, 2021. The launch of its latest Cannabis 2.0 offering is in partnership with Pax Labs, Inc. ("PAX"), a leader in premium cannabis vaporizer technology, with award-winning devices for both oil concentrates and flower.
    The Company's Starseed Medicinal-branded oil pods in award-winning strain-specific variants, using cannabis-derived terpenes produced in-house, will be available for purchase via its online medical store. WeedMD's adult-use Color Cannabis-branded PAX ERA pods are expected to be available through supply arrangements with provincial retailers commencing Q2, 2021.
    "In keeping with our long-standing tradition of releasing products first to our medical community, we're thrilled to launch the PAX ERA line-up in our award-winning Pedro's Sweet Sativa strain as the latest addition to our growing portfolio," said George Scorsis, Executive Chairman and CEO. "With product features that offer an updated medical experience, our teams worked together over the past few months to finely curate this portfolio of vaporizer products using our premier, quality-produced, strain-specific biomass. We're looking forward to expanding with additional terpene-rich strains such as Mango Haze and Black Sugar Rose, particularly as our next launch of concentrates will include our adult-use Color Cannabis-branded PAX ERA pods."
    PAX is a market leader with over two million devices sold worldwide and an established reputation as the best-selling pen-and-pod system in the U.S. Its closed-loop PAX ERA pods, for use with PAX's high-tech oil vaporizers, are dependable, leak-resistant and designed to be clog-free.
    WeedMD's partnership with PAX is expected to further accelerate the growth of the Company's Cannabis 2.0 product strategy as it continues to expand into new formats using its own indoor and outdoor-cultivated biomass, processed at its state-of-the-art extraction hub in Aylmer, Ontario. WeedMD currently produces terpene-infused 510-thread vape cartridges for its medical-branded Aurum vapes as well as its adult-use brands Color Cannabis and Saturday Cannabis.
    Bullish
  • T
    T.J.
    TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a federally licensed producer and distributor of medical-grade cannabis, announced today that it has amended and re-filed its unaudited reviewed interim financial statements for the three and nine months ended September 30, 2020 (the “ Amended Financial Statements ”), along with a corresponding restated management’s discussion and analysis (together with the Amended Financial Statements, the “ Amended Financial Reports ”). The Amended Financial Reports have been amended to recognize an impairment in the amount of $34,800,000 on goodwill, intangibles and property, plant and equipment and certain other non-material changes and were the result of management and the auditor’s review of the financial statements in support of the Company’s previously announced public offering of units.
  • e
    enrico
    Do you think Eight capital would but in 17 500 000$ without looking at the books?
    On February 11, 2021, the Company announced it has entered into a letter of engagement with Eight Capital, under which Eight capital has agreed to purchase, as joint bookrunner and co-lead underwriter along with Canaccord Genuity Corp., 21,342,000 units of the Company (the “Units”), on a bought deal basis at a price per Unit of $0.82 for gross proceeds of $17,500,440.

    Think about it.
  • N
    Neil
    i'll have to read the amended financials tomorrow but by the sounds of it at a glance they valued their assets for 38 million more on the books then what the actual value was. can you say lawsuit? ugh
  • J
    Jeff
    34 mil diff between unaudited and audited version. hold on to your seats how the market reacts.
  • e
    enrico
    Canopy is losing $3.80 per share!! Wmd is only losing 0.12$ per share.

    Thanks for your advice T.
    I'm holding WMD. I've been in Strathroy Ontario and visited the company. I saw
    many potentials in this company.
  • R
    Rayan
    I have 40k average 0.58. Long term hold. Target $1 by the end of the year.
  • d
    d
    it's either bad news late Friday or good news for monday. fingers crossed.
  • A
    AK
    There was closing of offering recently. That’s good enough reason for me to be long on this one. Time will say. If there is huge drop, I will avg. down. Good luck!!
  • j
    junk drawer
    Just about 35 mil just kind of isn’t there anymore... Oops
  • A
    Ayden
    Anyone know why trading is Halted?
  • e
    enrico
    More products out the company door = more revenue and better quarterly financials !!
  • S
    Scott
    if you want instant money buy a scratch ticket. stop being negative, buy more cheap shares and sit on them
  • R
    Ryan
    Looking into purchasing some stock. What’s people’s sentiment towards wmd
    Bullish
  • e
    enrico
    Impairment loss, It's ok, Just cleaning the books
    The Company has determined that there is only one CGU at the Company
    level. As a result of impairment testing, the Company determined an impairment loss of $34,800,000, representing the
    difference of the amount determined through Value in Use and the carrying value of the assets.
    The impairment loss has been allocated as follows:
    Goodwill - $16,123,601;
    Intangible assets - $12,376,399;
    Property, plant and equipment - $6,200,000; and
    Right of use assets -100,000
  • B
    Bee
    34 million in impairment/goodwill? #$%$ This is for the period ending Sept 30 and they forgot to mention this the first time they reported it? AGAIN, #$%$ I am not a rocket scientist but this rocket isn't taking off folks. I just bought back in with some profits and wish I wouldn't have now. This company is not on the up and up (liars/thieves). You don't just miss 34,000,000 in report and when an auditor looks it over again they have to pull a "oh, geez, we missed that, we'll make an amendment" after diluting 17.5 million more just after getting 30 million from Luna. Shareholders are being deceived. Company is no better than Aurora... build the company with shareholders money and bleed them dry. Then, when you got rich personally and the company has the parts in place, get a partner that will push the shareholder out even more even though they built this company. It is a crooked world we live in. There is nothing in this world you can own that the elitist can't take away from you by bending/changing the rules.... the American election is a perfect example. Amendment of quarterly??? Didn't fraud occur???
  • k
    kurt
    I wonder what they spent that money on thats not doing so well now
    Bullish
  • B
    Bee
    I don't believe the drop. I sold at .93 which was fortunate but I think this is way undervalued so I bought a few shares right now for .48. Not sure why I got it so cheap since a big institution bought in at .82 cents with warrant to be cashed over $1 so I am guessing they know the value and the value isn't 48 cents.
  • H
    Harish
    WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada
    WeedMD Rx Inc.
    Tue., February 16, 2021, 8:26 a.m.·9 min read
    WeedMD Announces Mary's Medicinals Product Launch in Canada
    Produced and distributed exclusively in Canada by WeedMD, Mary's Medicinals Transdermal Compound is the first in a suite of products to be released starting in late February 2021 to medical patients, followed by wider Ontario release expected in March 2021.
    Produced and distributed exclusively in Canada by WeedMD, Mary's Medicinals Transdermal Compound is the first in a suite of products to be released starting in late February 2021 to medical patients, followed by wider Ontario release expected in March 2021.
    More
    Produced and distributed exclusively in Canada by WeedMD, Mary's Medicinals Transdermal Compound is the first in a suite of products to be released starting in late February 2021 to medical patients, followed by wider Ontario release expected in March 2021.
    Scroll to continue with contentAd
    L'audace N'attend Personne
    L'audace N'attend Personne
    L'audace N'attend Personne
    L'audace N'attend Personne
    L'audace N'attend Personne
    L'audace N'attend Personne
    Acclaimed Mary’s Medicinals Transdermal Compound, produced exclusively in Canada by WeedMD, with expected availability to Starseed Medicinal’s patients starting late February, 2021

    Mary’s Medicinals expanded availability in Ontario expected in March 2021

    Additional new product formats, including transdermal gels and patches, are expected to follow with later expansion to more provinces

    TORONTO, Feb. 16, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the Canadian launch of acclaimed U.S.-based wellness brand Mary’s Medicinals, part of the Mary’s Brands ("Mary’s”) portfolio, and a BellRock Brands Inc. ("BellRock") (CSE: BRCK.U) company. As the exclusive manufacturer and distributor for Mary’s Medicinals’ suite of products in Canada, WeedMD will launch Mary’s Medicinals Transdermal Compound topical as its first release, with expected availability to the Company’s Starseed Medicinal patients starting late February, 2021. WeedMD will expand availability starting with Ontario expected in March 2021, to be followed by additional provinces. The launch will eventually expand to include new product formats, including Mary’s Medicinals transdermal gels and patches, and will become available to both medical and direct-to-consumer markets.

    WeedMD is processing Mary’s Medicinals compound in-house at its Aylmer, ON-based extraction hub, using its own indoor and outdoor-input biomass. The Company’s product development and extraction teams are using Mary’s proprietary and patented technology which calls for extracting CBD, THC and CBN – the active cannabinoid ingredients used to produce rich transdermal compounds. The extracts and resins are formulated together with naturally sourced mango butter, locally-sourced beeswax and menthol ingredients to produce Mary’s Medicinals topical products, which have been shown to provide targeted relief and deeper penetration than traditional cannabis topicals.

    “We’re excited to be launching Mary’s Medicinals acclaimed therapeutic-based cannabis products in Canada - an important milestone as we expand our line-up with trusted Cannabis 2.0 additions,” said George Scorsis, Executive Chairman and Interim CEO, WeedMD. “We set out to produce CBD, THC and CBN-rich extracts in order to formulate new cannabis formats for an underserved patient and consumer segment looking for high-value, premium self-care products. As Mary’s Medicinals’ exclusive partner, we are proud to be introducing and delivering these high-calibre topical products to our local markets and taking a dominant position in this segment with a trusted brand.”

    “Canada has long been regarded as a pioneering cannabis nation and we’re thrilled to be expanding Mary’s Medicinals’ product reach into this important market alongside our local partner WeedMD,” said Chuck Smith, CEO of BellRock. “Our collaboration comes at a time when there is a greater acceptance of diverse and novel cannabis delivery methods and an evolving consumer base. We’re looking forward to expanding into new and exciting distribution channels across the continent with such a lauded partner.”

    Story continues.
  • e
    enrico
    Buffett has made money consistently for decades from the stock market. He simply believes in buying good cheap stocks for the long-term to grow money. Buffett also prefers to invest his money in industries that have good future growth potential.
    I am long on Wmd and believe this company has great products.